Mounjaro Dosing: Your Guide to How and When to Take It

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide injection combines two powerful hormonal pathways—GLP-1 and GIP signaling—to reduce appetite and improve blood sugar control. Unlike older single-pathway medications, this dual-action compound requires a gradual dosing schedule to minimize side effects while maximizing weight loss results. PlexusDx delivers compounded tirzepatide injections from licensed 503A pharmacies, with transparent pricing that stays flat regardless of your dose strength.

Understanding Tirzepatide Injection Dose Escalation

Tirzepatide dosing follows a step-wise escalation protocol designed to help your body adapt to the medication over 16 to 20 weeks. Most patients begin at the lowest available dose and increase by increments every four weeks, provided they tolerate the current dose well. This gradual approach reduces nausea, vomiting, and gastrointestinal side effects that can occur with rapid dose jumps. Clinical trials showed that patients who completed the full titration schedule achieved significantly better weight loss outcomes than those who skipped levels. PlexusDx providers customize your escalation timeline based on your individual response and medical history.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Weekly Injection Timing and Administration Schedule

Tirzepatide is administered once weekly via subcutaneous injection, meaning you inject it under the skin in the abdomen, thigh, or upper arm. The exact day of the week you choose is flexible—many patients select the same day to build routine consistency. Injections should be spaced seven days apart, though timing within a 24-hour window on either side does not significantly impact efficacy. You can self-administer the injection at home using a pre-filled pen after brief training from your PlexusDx care team. Store unused pens in the refrigerator and allow the pen to reach room temperature for about 15 minutes before injection to reduce discomfort.

Most patients experience minimal pain during the injection itself, as the needle is very small and injection depth is shallow. Mark your calendar or set a smartphone reminder for your weekly injection day to maintain consistent dosing intervals. If you miss a weekly dose by one to two days, inject as soon as you remember and resume your normal schedule the following week. Do not take two doses in one week to make up for a missed injection. PlexusDx provides detailed injection training videos and 24/7 access to your clinical team if you have questions about your administration technique.

How Your Dose May Increase Over Time

Tirzepatide doses typically progress through standard increments: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per week. Your provider may move you to the next level every four weeks if your current dose is well-tolerated and weight loss has plateaued. Some patients reach their goal weight at a lower dose and choose to stay there indefinitely, while others continue escalating to maximize appetite suppression. The highest approved dose, 15 mg weekly, is where most patients see the full metabolic benefit of the dual GLP-1/GIP pathway. Research from clinical trials shows that doses above 10 mg produce the most dramatic weight loss in the majority of participants.

PlexusDx monitors your progress through regular check-ins and adjusts your prescription as needed—your dose may go up, but your price will not. This flat-rate pricing model removes the financial anxiety many patients feel when considering dose escalation. Whether you're on 2.5 mg or 15 mg per week, your compounded tirzepatide injection remains the same monthly cost, making it predictable and affordable to find your optimal dose.

Personalizing Your Tirzepatide Protocol with Genetic Insight

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Beyond tirzepatide responsiveness, the Precision Peptide Genetic Test maps 14 metabolic pathways and 150+ insights across 49 peptides to optimize your entire weight loss plan. Some patients qualify for dual-compound therapy—GLP-Squared Injection, which combines semaglutide and tirzepatide—based on their genetic profile and clinical needs. PlexusDx uses your genetic data to eliminate guesswork and design a medication protocol aligned with your body's unique chemistry, not a one-size-fits-all standard.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of tirzepatide, and how long until I reach full dose?

Most patients begin at 2.5 mg once weekly and increase by 2.5 mg increments every four weeks if tolerated well. Reaching the therapeutic dose of 10 mg typically takes 12 to 16 weeks; reaching the maximum dose of 15 mg takes 20 weeks or longer. PlexusDx customizes your titration timeline based on your side effect profile and weight loss progress.

Can I inject tirzepatide on different days each week, or does it have to be the same day?

Ideally, you should inject on the same day each week to maintain consistent drug levels. However, injecting within 24 hours before or after your scheduled day will not significantly reduce efficacy. PlexusDx recommends setting a calendar reminder to maintain consistency and avoid accidental double-dosing.

Does PlexusDx charge more if my dose increases over time?

No. PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) flat, and your price remains fixed regardless of whether you escalate from 2.5 mg to 15 mg. This transparent, dose-flat pricing removes financial barriers to reaching your optimal therapeutic dose.

What happens if I experience severe nausea or side effects during dose escalation?

Notify your PlexusDx provider immediately if nausea, vomiting, or other side effects become intolerable. Your provider may delay your next dose increase, hold your current dose longer, or lower your dose temporarily to allow adjustment. Never stop injecting without clinical guidance, as abrupt discontinuation can cause rebound hunger and weight regain.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.